Hikma Pharmaceuticals Plc Director/PDMR Shareholding (8588H)
June 12 2017 - 11:31AM
UK Regulatory
TIDMHIK
RNS Number : 8588H
Hikma Pharmaceuticals Plc
12 June 2017
Hikma Pharmaceuticals PLC - Vesting of LTIP
LONDON, 12 June 2017: Hikma Pharmaceuticals PLC (LSE: HIK)
(NasdaqDubai: HIK) ("Hikma") (LEI: 549300BNS685UXH4JI75) announces
that the following Persons Discharging Managerial Responsibility
("PDMR") have received shares as a result of the vesting of their
conditional share awards on 11 June 2017 under the 2005 Long Term
Incentive Plan ("LTIP") which was completed on 12 June 2017. These
awards were automatically exercised by operation of the conditional
award and vesting process. The exercise price under the LTIP is
GBPnil.
Notification and public disclosure of transactions by persons
discharging managerial responsibilities
1 Details of the person discharging managerial
responsibilities / person closely associated
--- -----------------------------------------------------------
a) Name Khalid Nabilsi
--- --------------------- ------------------------------------
2 Reason for the notification
--- -----------------------------------------------------------
a) Position/status Chief Financial Officer
--- --------------------- ------------------------------------
b) Initial notification Initial notification
/Amendment
--- --------------------- ------------------------------------
3 Details of the issuer, emission allowance market
participant, auction platform, auctioneer or
auction monitor
--- -----------------------------------------------------------
a) Name Hikma Pharmaceuticals PLC
--- --------------------- ------------------------------------
b) LEI 549300BNS685UXH4JI75
--- --------------------- ------------------------------------
4 Details of the transaction(s): section to be
repeated for (i) each type of instrument; (ii)
each type of transaction; (iii) each date;
and (iv) each place where transactions have
been conducted
--- -----------------------------------------------------------
a) Description Description: Ordinary shares of 10
of the financial pence each (Shares)
instrument, ID Code: GB00B0LCW083
type of instrument
and identification
code
--- --------------------- ------------------------------------
b) Nature of Shares acquired from vesting of the
the transaction conditional awards on 11 June 2017
under the LTIP.
--- --------------------- ------------------------------------
c) Price(s) and Price(s): GBPnil
volume(s) Volume(s): 12,842
--- --------------------- ------------------------------------
d) Aggregated N/A
information
--- --------------------- ------------------------------------
e) Date of the 12 June 2017
transaction
--- --------------------- ------------------------------------
f) Place of the London Stock Exchange (XLON)
transaction
--- --------------------- ------------------------------------
1 Details of the person discharging managerial
responsibilities / person closely associated
--- -----------------------------------------------------------
a) Name Riad Mishlawi
--- --------------------- ------------------------------------
2 Reason for the notification
--- -----------------------------------------------------------
a) Position/status EU Vice President and Global Head
of Injectables
--- --------------------- ------------------------------------
b) Initial notification Initial notification
/Amendment
--- --------------------- ------------------------------------
3 Details of the issuer, emission allowance market
participant, auction platform, auctioneer or
auction monitor
--- -----------------------------------------------------------
a) Name Hikma Pharmaceuticals PLC
--- --------------------- ------------------------------------
b) LEI 549300BNS685UXH4JI75
--- --------------------- ------------------------------------
4 Details of the transaction(s): section to be
repeated for (i) each type of instrument; (ii)
each type of transaction; (iii) each date;
and (iv) each place where transactions have
been conducted
--- -----------------------------------------------------------
a) Description Description: Ordinary shares of 10
of the financial pence each (Shares)
instrument, ID Code: GB00B0LCW083
type of instrument
and identification
code
--- --------------------- ------------------------------------
b) Nature of Shares acquired from vesting of the
the transaction conditional awards on 11 June 2017
under the LTIP.
--- --------------------- ------------------------------------
c) Price(s) and Price(s): GBPnil
volume(s) Volume(s): 12,521
--- --------------------- ------------------------------------
d) Aggregated N/A
information
--- --------------------- ------------------------------------
e) Date of the 12 June 2017
transaction
--- --------------------- ------------------------------------
f) Place of the London Stock Exchange (XLON)
transaction
--- --------------------- ------------------------------------
1 Details of the person discharging managerial
responsibilities / person closely associated
---------------------------------------------------------
a) Name Michael Raya
-------------------- -----------------------------------
2 Reason for the notification
---------------------------------------------------------
a) Position/status CEO of West-Ward Pharmaceuticals
-------------------- -----------------------------------
b) Initial notification Initial notification
/Amendment
-------------------- -----------------------------------
3 Details of the issuer, emission allowance market
participant, auction platform, auctioneer or
auction monitor
---------------------------------------------------------
a) Name Hikma Pharmaceuticals PLC
-------------------- -----------------------------------
b) LEI 549300BNS685UXH4JI75
-------------------- -----------------------------------
4 Details of the transaction(s): section to be
repeated for (i) each type of instrument; (ii)
each type of transaction; (iii) each date;
and (iv) each place where transactions have
been conducted
---------------------------------------------------------
a) Description Description: Ordinary shares of 10
of the financial pence each (Shares)
instrument, ID Code: GB00B0LCW083
type of instrument
and identification
code
-------------------- -----------------------------------
b) Nature of Shares acquired from vesting of the
the transaction conditional awards on 11 June 2017
under the LTIP.
-------------------- -----------------------------------
c) Price(s) and Price(s): GBPnil
volume(s) Volume(s): 19,244
-------------------- -----------------------------------
d) Aggregated N/A
information
-------------------- -----------------------------------
e) Date of the 12 June 2017
transaction
-------------------- -----------------------------------
f) Place of the London Stock Exchange (XLON)
transaction
-------------------- -----------------------------------
1 Details of the person discharging managerial
responsibilities / person closely associated
--------------------------------------------------------------
a) Name Bassam Kanaan
-------------------- ----------------------------------------
2 Reason for the notification
--------------------------------------------------------------
a) Position/status Chief Strategy and Corporate Development
Officer
-------------------- ----------------------------------------
b) Initial notification Initial notification
/Amendment
-------------------- ----------------------------------------
3 Details of the issuer, emission allowance market
participant, auction platform, auctioneer or
auction monitor
--------------------------------------------------------------
a) Name Hikma Pharmaceuticals PLC
-------------------- ----------------------------------------
b) LEI 549300BNS685UXH4JI75
-------------------- ----------------------------------------
4 Details of the transaction(s): section to be
repeated for (i) each type of instrument; (ii)
each type of transaction; (iii) each date;
and (iv) each place where transactions have
been conducted
--------------------------------------------------------------
a) Description Description: Ordinary shares of 10
of the financial pence each (Shares)
instrument, ID Code: GB00B0LCW083
type of instrument
and identification
code
-------------------- ----------------------------------------
b) Nature of Shares acquired from vesting of the
the transaction conditional awards on 11 June 2017
under the LTIP.
-------------------- ----------------------------------------
c) Price(s) and Price(s): GBPnil
volume(s) Volume(s): 20,341
-------------------- ----------------------------------------
d) Aggregated N/A
information
-------------------- ----------------------------------------
e) Date of the 12 June 2017
transaction
-------------------- ----------------------------------------
f) Place of the London Stock Exchange (XLON)
transaction
-------------------- ----------------------------------------
1 Details of the person discharging managerial
responsibilities / person closely associated
---------------------------------------------------------
a) Name Majda Labadi
-------------------- -----------------------------------
2 Reason for the notification
---------------------------------------------------------
a) Position/status Corporate Vice President for Human
Resources and Head of Operations,
MENA
-------------------- -----------------------------------
b) Initial notification Initial notification
/Amendment
-------------------- -----------------------------------
3 Details of the issuer, emission allowance market
participant, auction platform, auctioneer or
auction monitor
---------------------------------------------------------
a) Name Hikma Pharmaceuticals PLC
-------------------- -----------------------------------
b) LEI 549300BNS685UXH4JI75
-------------------- -----------------------------------
4 Details of the transaction(s): section to be
repeated for (i) each type of instrument; (ii)
each type of transaction; (iii) each date;
and (iv) each place where transactions have
been conducted
---------------------------------------------------------
a) Description Description: Ordinary shares of 10
of the financial pence each (Shares)
instrument, ID Code: GB00B0LCW083
type of instrument
and identification
code
-------------------- -----------------------------------
b) Nature of Shares acquired from vesting of the
the transaction conditional awards on 11 June 2017
under the LTIP.
-------------------- -----------------------------------
c) Price(s) and Price(s): GBPnil
volume(s) Volume(s): 9,879
-------------------- -----------------------------------
d) Aggregated N/A
information
-------------------- -----------------------------------
e) Date of the 12 June 2017
transaction
-------------------- -----------------------------------
f) Place of the London Stock Exchange (XLON)
transaction
-------------------- -----------------------------------
This information is provided by RNS
The company news service from the London Stock Exchange
END
DSHBUGDLCDBBGRD
(END) Dow Jones Newswires
June 12, 2017 11:31 ET (15:31 GMT)
Hikma Pharmaceuticals (LSE:HIK)
Historical Stock Chart
From Jun 2024 to Jul 2024
Hikma Pharmaceuticals (LSE:HIK)
Historical Stock Chart
From Jul 2023 to Jul 2024
